Medtronic gains fda clearance of unid™ patient-specific rods for use with cd horizon™ solera™ voyager™ and infinity™ oct spinal systems

Dublin, june 3, 2021 /prnewswire/ -- medtronic plc (nyse:mdt), the global leader in medical technology, today announced the u.s. food and drug administration (fda) clearance of patient-specific unid™ rods for use with medtronic cd horizon™ solera™ voyager™ and infinity™ oct spinal systems, expanding the utility of the company's unid™ adaptative spine intelligence (asi) technology. unid rods are designed for each patient and industrially pre-bent prior to surgery to accurately match an artificial intelligence (ai)-driven pre-operative surgical plan, which is created with unid™ asi technology to precisely align patients' spines1 ,2, reducing the risk of malalignment and associated revision surgeries.3 unid rods are used to treat scoliosis, trauma, tumors, and complex degenerative conditions in adults and adolescent idiopathic scoliosis.
MDT Ratings Summary
MDT Quant Ranking